Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already establish readOnlyHint, openWorldHint, idempotentHint, and destructiveHint=false, so the safety profile is covered. The description adds rich behavioral detail beyond annotations: ambiguous matches 'assert nothing' and return figi_candidates, unresolved identifiers are explicitly listed, LEI/FIGI enrichment 'degrades gracefully', and the call cascades through multiple endpoints internally. This is exactly the kind of non-obvious runtime behavior an agent needs.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long and dense, but it is organized with front-loaded question examples, a clear 'Use FIRST' directive, and labeled SUPPORTED TYPES sections. The parenthetical edge-case detail is substantial and mostly earns its place, though a few clauses (e.g., the extensive FIGI coverage exegesis) could be tightened without losing meaning.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description must explain what the tool returns, and it does: each identifier is labeled with its source, unresolved identifiers are listed explicitly under `unresolved`, ambiguous matches return `figi_candidates`, and enrichment failures still yield EDGAR identifiers. This gives an agent a complete mental model of the tool's behavior across success, ambiguity, and partial-failure paths.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the baseline is 3, but the description substantially enriches parameter meaning. It clarifies the exact format for value (ticker, CIK, ISIN, or name; brand or generic for drug) and adds a critical pitfall warning: pass only the entity name, never the full noun phrase, because 'trailing security-class words match nothing'. It also explains that an ISIN resolves to the legal entity that issued the security, which the schema alone does not convey.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description defines a specific action ('resolve a user-spoken NAME to the canonical/official identifiers') and clearly distinguishes the tool from siblings like compare_entities and entity_profile by positioning it as the prerequisite step that 'other tools require as input'. The two supported types, 'company' and 'drug', are enumerated with exact identifier outputs.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives explicit trigger conditions ('Use FIRST whenever you have a name but need an ID') and realistic user phrasings, which makes when-to-use highly clear. It does not explicitly state when not to use it or name alternative tools to prefer instead, but the context is strong enough that exclusions are not necessary for safe invocation.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation2/5

Several tools overlap heavily: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, and deep_research all route questions to the same 5,529-tool catalog, with ask_pipeworx_beta currently identical to ask_pipeworx. The Polymarket suite also has ambiguous boundaries (bet_research vs. polymarket_edges vs. polymarket_arbitrage), and scan_competitor_ai_presence simply wraps ai_visibility_check, so agents may struggle to choose the right tool.

Naming Consistency3/5

All names are snake_case and readable, but the set mixes verb-led names (ask_pipeworx, compare_entities, scan_dependency, validate_claim, hts_search) with noun-led names (entity_profile, recent_alerts, polymarket_edges, ai_visibility_check). Variant suffixes like ask_pipeworx_beta / ask_pipeworx_grounded add further inconsistency, so the naming is coherent enough but not predictable enough for a 4.

Tool Count2/5

At 33 tools, the server exceeds the 25-tool threshold for 'too many' in the rubric. Even though the broad data-research scope justifies a larger surface, the count feels bloated because several tools are near-duplicates (e.g., ask_pipeworx_beta, ask_pipeworx_grounded) or wrappers (scan_competitor_ai_presence), making the set heavier than necessary.

Completeness4/5

The server covers its core domains thoroughly: data querying (ask_pipeworx family, deep_research), entity resolution and comparison (resolve_entity, entity_profile, compare_entities), verification (validate_claim, ask_pipeworx_grounded), HTS tariff lookup (search + detail), subscription lifecycle (subscribe/unsubscribe/list/recent_alerts), and memory (remember/recall/forget). Minor gaps exist, such as no subscription-update endpoint and no generic raw-source export, but these are workaround-able and do not cause agent failures.